May 11, 2022 – IQ Endoscopes granted ISO 13485 certification
IQ Endoscopes, a medical device company creating a single use endoscopy platform that enables the early diagnosis of gastro-intestinal diseases, has been granted ISO 13485 certification. This accreditation provides the basis of all medical device manufacturers to ensure safe and effective products and services. This achievement is an exciting opportunity for the company and puts us one step closer towards reaching regulatory approval for our endoscopy portfolio.
IQ Endoscopes was founded by Dr Patrick Ward-Booth in 2015 after 40 years’ experience in the field of endoscopy. He realised the huge impact a single use endoscope could have on the provision of an efficient global service. By incorporating a strong approach to materials and manufacturing, they are developing a single use endoscopy platform that will match current reusable technology in ergonomics and physical functionality whilst remaining affordable. This accreditation is the latest achievement from IQ Endoscopes, who also completed a £4 million equity fund and won the MediWales Innovation Awards Start-up of the Year award in Q4 of 2021.
Chris Jenkins, Head of Quality, Regulatory and Compliance at IQ Endoscopes reflected, “Being granted ISO 13485 accreditation displays IQ Endoscopes’ commitment to instilling quality into the core of our activity, both internally and externally. This provides the foundation for us to establish a consistent and standardised approach to all aspects of product lifecycle management to ensure safe and effective products and services.”
“I would like to take this opportunity to thank the team for their involvement in this accomplishment and for receiving such good feedback. We also appreciate the approach of the auditor in engaging with us and helping us to realise our goal.”
Matt Ginn, CEO at IQ Endoscopes commented, “ISO 13485 reinforces the importance and criticality of quality and compliance which we strive to keep at the heart of our business. This accreditation is key to accelerating our regulatory approval strategy, allowing us to bring our disruptive technology to market and make it available to patients as soon as possible.”
Media contact | IQ Endoscopes